These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 8260229)
1. Improvement of the diagnosis of the cause of pleural effusion in patients with lung cancer by simultaneous quantification of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) pleural levels. Menard O; Dousset B; Jacob C; Martinet Y Eur J Cancer; 1993; 29A(13):1806-9. PubMed ID: 8260229 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions. Ferrer J; Villarino MA; Encabo G; Felip E; Bermejo B; Vilà S; Orriols R Cancer; 1999 Oct; 86(8):1488-95. PubMed ID: 10526277 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer. Lee JH; Chang JH Chest; 2005 Oct; 128(4):2298-303. PubMed ID: 16236887 [TBL] [Abstract][Full Text] [Related]
4. [Diagnostic utility of carcinoembryonic antigen, neuron-specific enolase and squamous cell carcinoma antigen in malignant pleural effusion]. Sánchez de Cos Escuín J; López Parra S; Disdier Vicente C; Martín Vicente MJ; Masa Jiménez JF; Domínguez Retortillo C An Med Interna; 1996 Aug; 13(8):369-73. PubMed ID: 8983362 [TBL] [Abstract][Full Text] [Related]
5. Neuron-specific enolase in the diagnosis of small-cell lung cancer with pleural effusion: a negative report. Pettersson T; Klockars M; Fröseth B Eur Respir J; 1988 Aug; 1(8):698-700. PubMed ID: 2853080 [TBL] [Abstract][Full Text] [Related]
6. Lung surfactant protein-A and carcinoembryonic antigen in pleural effusions due to lung adenocarcinoma and malignant mesothelioma. Shijubo N; Honda Y; Fujishima T; Takahashi H; Kodama T; Kuroki Y; Akino T; Abe S Eur Respir J; 1995 Mar; 8(3):403-6. PubMed ID: 7789485 [TBL] [Abstract][Full Text] [Related]
7. Utility of tumour markers in the diagnosis of neoplastic pleural effusion. San Jose ME; Alvarez D; Valdes L; Sarandeses A; Valle JM; Penela P Clin Chim Acta; 1997 Sep; 265(2):193-205. PubMed ID: 9385461 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of tumor markers for differentiating malignant and benign pleural effusions of Iranian patients. Ghayumi SM; Mehrabi S; Doroudchi M; Ghaderi A Pathol Oncol Res; 2005; 11(4):236-41. PubMed ID: 16388321 [TBL] [Abstract][Full Text] [Related]
9. Use of tumor markers in distinguishing lung adenocarcinoma-associated malignant pleural effusion from tuberculous pleural effusion. Ai L; Wang W; Li J; Ye T; Li Y Am J Med Sci; 2024 Aug; 368(2):136-142. PubMed ID: 38583522 [TBL] [Abstract][Full Text] [Related]
10. [Tumor markers in pleural effusion of patients with lung cancer and patients with tuberculous pleurisy]. Tada A; Kawai H; Matsumoto H; Kimura G; Okada C; Soda R; Takahashi K Nihon Kokyuki Gakkai Zasshi; 2002 Feb; 40(2):106-12. PubMed ID: 11974864 [TBL] [Abstract][Full Text] [Related]
11. Use of cholesterol and soluble tumour markers CEA and syndecan-2 in pleural effusions in cases of inconclusive cytology. Gulyas M; Fillinger J; Kaposi AD; Molnar M J Clin Pathol; 2019 Aug; 72(8):529-535. PubMed ID: 31028099 [TBL] [Abstract][Full Text] [Related]
12. [Value of tumor markers series of hydrothorax in differential diagnosis of pleural effusion]. Liu YQ; Zhang HL; Gao WJ; Lan X; Yuan BJ; Zou JM Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Jan; 26(1):34-8. PubMed ID: 18302890 [TBL] [Abstract][Full Text] [Related]
13. The role of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) evaluation in pericardial fluid for the recognition of malignant pericarditis. Szturmowicz M; Tomkowski W; Fijalkowska A; Burakowski J; Sakowicz A; Filipecki S Int J Biol Markers; 1997; 12(3):96-101. PubMed ID: 9479590 [TBL] [Abstract][Full Text] [Related]
14. [Diagnostic usefulness of neurospecific enolase determination in pleural fluid]. Romero S; Izquierdo M; Mauri M; Martín C; Almenar MV; García R; Padilla I Med Clin (Barc); 1989 Nov; 93(15):568-71. PubMed ID: 2622261 [TBL] [Abstract][Full Text] [Related]
15. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670 [TBL] [Abstract][Full Text] [Related]
16. CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause. Wang XF; Wu YH; Wang MS; Wang YS Asian Pac J Cancer Prev; 2014; 15(1):363-8. PubMed ID: 24528057 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous enzyme immunoassay of carcinoembryonic antigen in pleural effusion and serum. Asseo PP; Tracopoulos GD Am J Clin Pathol; 1982 Jan; 77(1):66-71. PubMed ID: 7034521 [TBL] [Abstract][Full Text] [Related]
18. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type]. Klech H; Rona G; Hutter C; Bayer PM; Kummer F Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811 [TBL] [Abstract][Full Text] [Related]
19. Limited additive value of pleural fluid carcinoembryonic antigen level in malignant pleural effusion. Riantawan P; Sangsayan P; Bangpattanasiri K; Rojanaraweewong P Respiration; 2000; 67(1):24-9. PubMed ID: 10705258 [TBL] [Abstract][Full Text] [Related]
20. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion]. Wei F; Wei Y; Li LF; Li GL; Wang GJ Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299 [No Abstract] [Full Text] [Related] [Next] [New Search]